Host responses from innate to adaptive immunity after vaccination: Molecular and cellular events

Molecules and Cells

Volumn 27, Issue 1, 2009, Pages 5-14

  Kang, Sang Moo ^a   Compans, Richard W ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adaptive; Immune responses; Innate; Memory B cells; Pathogen; Plasma cells; Signaling; TLRs; Vaccine; VLPs

Indexed keywords

CXCL13 CHEMOKINE; IMMUNOGLOBULIN G; INFLUENZA VACCINE; INTERFERON REGULATORY FACTOR; LIVE VACCINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; VACCINE;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; DENDRITIC CELL; FOLLICULAR DENDRITIC CELL; GENE REARRANGEMENT; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; MACROPHAGE; MEMORY CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TH1 CELL; UPREGULATION; VACCINATION; VIRUS LIKE AGENT; VIRUS PARTICLE; ANIMAL; HUMAN; IMMUNOLOGY; REVIEW; VIRUS;

ANIMALS; ANTIGEN-PRESENTING CELLS; HUMANS; IMMUNITY, INNATE; SIGNAL TRANSDUCTION; VACCINATION; VACCINES; VIRUSES;

EID: 62849108482     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0015-1     Document Type: Short Survey

References (114)

1. S. Akira 2006 TLR signaling Curr. Top Microbiol. Immunol. 311 1 16 17048703 1:CAS:528:DC%2BD28Xht1WrsbjE 10.1007/3-540-32636-7-1
2. S. Akira M. Yamamoto K. Takeda 2003 Role of adapters in Toll-like receptor signalling Biochem. Soc. Trans. 31 637 642 12773172 1:CAS:528:DC%2BD3sXktF2iurY%3D 10.1042/BST0310637 (Pubitemid 36750746)
3. S. Akira S. Uematsu O. Takeuchi 2006 Pathogen recognition and innate immunity Cell 124 783 801 16497588 1:CAS:528:DC%2BD28Xit1Kltb8%3D 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
4. J.B. Alarcon A.W. Hartley N.G. Harvey J.A. Mikszta 2007 Preclinical evaluation of microneedle technology for intradermal delivery of influenza vaccines Clin. Vaccine Immunol. 14 375 381 17329444 1:CAS:528: DC%2BD2sXkvVSktrw%3D 10.1128/CVI.00387-06 (Pubitemid 46732547)
5. P. Auewarakul U. Kositanont P. Sornsathapornkul P. Tothong R. Kanyok P. Thongcharoen 2007 Antibody responses after dose-sparing intradermal influenza vaccination Vaccine 25 659 663 17011678 1:CAS:528:DC%2BD28Xht12rurfM 10.1016/j.vaccine.2006.08.026 (Pubitemid 44856109)
6. M.F. Bachmann R.M. Zinkernagel A. Oxenius 1998 Immune responses in the absence of costimulation: viruses know the trick J. Immunol. 161 5791 5794 9834052 1:CAS:528:DyaK1cXnslCrsr8%3D
7. G.M. Barton R. Medzhitov 2003 Toll-like receptor signaling pathways Science 300 1524 1525 12791976 1:CAS:528:DC%2BD3sXktlKru7w%3D 10.1126/science.1085536 (Pubitemid 36682871)
8. N.L. Bernasconi E. Traggiai A. Lanzavecchia 2002 Maintenance of serological memory by polyclonal activation of human memory B cells Science 298 2199 2202 12481138 1:CAS:528:DC%2BD38XpsVSktLs%3D 10.1126/science.1076071 (Pubitemid 35471246)
9. A. Bertolotti-Ciarlet M. Ciarlet S.E. Crawford M.E. Conner M.K. Estes 2003 Immunogenicity and protective efficacy of rotavirus 2/6-virus-like particles produced by a dual baculovirus expression vector and administered intramuscularly, intranasally, or orally to mice Vaccine 21 3885 3900 12922123 1:CAS:528:DC%2BD3sXmt1GkurY%3D 10.1016/S0264-410X(03)00308-6 (Pubitemid 37338216)
10. B. Beutler K. Hoebe P. Georgel K. Tabeta X. Du 2004 Genetic analysis of innate immunity: TIR adapter proteins in innate and adaptive immune responses Microbes Infect 6 1374 1381 15596123 1:CAS:528:DC%2BD2cXhtVOntbbO 10.1016/j.micinf.2004.08.017 (Pubitemid 41110580)
11. V. Blazevic C.M. Trubey G.M. Shearer 2000 Comparison of in vitro immunostimulatory potential of live and inactivated influenza viruses Hum. Immunol. 61 845 849 11053627 1:CAS:528:DC%2BD3cXosVWlu70%3D 10.1016/S0198- 8859(00)00170-1 (Pubitemid 30797908)
12. E.J. Blink A. Light A. Kallies S.L. Nutt P.D. Hodgkin D.M. Tarlinton 2005 Early appearance of germinal center-derived memory B cells and plasma cells in blood after primary immunization J. Exp. Med. 201 545 554 15710653 1:CAS:528:DC%2BD2MXhs1KmsLY%3D 10.1084/jem.20042060 (Pubitemid 40289545)
13. A. Bowie L.A. O'Neill 2000 The interleukin-1 receptor/Tolllike receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products J. Leukoc. Biol. 67 508 514 10770283 1:CAS:528:DC%2BD3cXkvVygtrw%3D
14. R.A. Bright D.M. Carter C.J. Crevar F.R. Toapanta J.D. Steckbeck K.S. Cole N.M. Kumar P. Pushko G. Smith T.M. Tumpey, et al. 2008 Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle PLoS ONE 3 e1501 18231588 10.1371/journal. pone.0001501 1:CAS:528:DC%2BD1cXhvFClu7c%3D (Pubitemid 351827197)
15. L. Buonaguro M.L. Tornesello M. Tagliamonte R.C. Gallo L.X. Wang R. Kamin-Lewis S. Abdelwahab G.K. Lewis F.M. Buonaguro 2006 Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses J. Virol. 80 9134 9143 16940524 1:CAS:528:DC%2BD28XpvVGhsrY%3D 10.1128/JVI.00050-06 (Pubitemid 44362963)
16. L. Buonaguro A. Monaco E. Arico E. Wang M.L. Tornesello G.K. Lewis F.M. Marincola F.M. Buonaguro 2008 Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation BMC Bioinformatics 9 S5 18387207 10.1186/1471-2105-9-S2-S5 1:CAS:528:DC%2BD1cXhtFWgur%2FN (Pubitemid 351959551)
17. P.D. Burrows M.D. Cooper 1997 B cell development and differentiation Curr. Opin. Immunol. 9 239 244 9099791 1:CAS:528:DyaK2sXivFWhsrc%3D 10.1016/S0952-7915(97)80142-2 (Pubitemid 27190125)
18. B. Cairns R. Maile C.M. Barnes J.A. Frelinger A.A. Meyer 2006 Increased Toll-like receptor 4 expression on T cells may be a mechanism for enhanced T cell response late after burn injury J. Trauma 61 293 298 16917441 10.1097/01.ta.0000228969.46633.bb
19. R.H. Carter D.T. Fearon 1992 CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes Science 256 105 107 1373518 1:CAS:528:DyaK38XitFamtrk%3D 10.1126/science.1373518
20. R.H. Carter M.O. Spycher Y.C. Ng R. Hoffman D.T. Fearon 1988 Synergistic interaction between complement receptor type 2 and membrane IgM on B lymphocytes J. Immunol. 141 457 463 2968402 1:CAS:528:DyaL1cXkvFWjtb0%3D
21. Chen, W., and Gluud, C. (2005). Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst. Rev. (4), CD000100.
22. M. Chilosi F. Adami M. Lestani L. Montagna L. Cimarosto G. Semenzato G. Pizzolo F. Menestrina 1999 CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies Mod. Pathol. 12 1101 1106 10619261 1:STN:280:DC%2BD3c%2FosVakuw%3D%3D
23. J.P. Coutelier J.T. van der Logt F.W. Heessen G. Warnier J. Van Snick 1987 IgG2a restriction of murine antibodies elicited by viral infections J. Exp. Med. 165 64 69 3794607 1:CAS:528:DyaL2sXot1OksA%3D%3D 10.1084/jem.165.1.64
24. S. Crotty P. Felgner H. Davies J. Glidewell L. Villarreal R. Ahmed 2003 Cutting edge: long-term B cell memory in humans after smallpox vaccination J. Immunol. 171 4969 4973 14607890 1:CAS:528:DC%2BD3sXoslyjsLc%3D
25. S. Crotty R.D. Aubert J. Glidewell R. Ahmed 2004 Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system J. Immunol. Methods 286 111 122 15087226 1:CAS:528:DC%2BD2cXjt1Cht7c%3D 10.1016/j.jim.2003.12.015 (Pubitemid 38490401)
26. F. de Lalla E. Rinaldi D. Santoro G. Pravettoni 1988 Immune response to hepatitis B vaccine given at different injection sites and by different routes: a controlled randomized study Eur. J. Epidemiol. 4 256 258 2969825 10.1007/BF00144763
27. L. Deml R. Schirmbeck J. Reimann H. Wolf R. Wagner 1997 Recombinant human immunodeficiency Pr55gag viruslike particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies Virology 235 26 39 9300034 1:CAS:528:DyaK2sXlsFGjtrk%3D 10.1006/viro.1997.8668 (Pubitemid 27380803)
28. L. Deml C. Speth M. P. Dierich H. Wolf R. Wagner 2005 Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses Mol. Immunol. 42 259 277 15488613 1:CAS:528:DC%2BD2cXosFSmsbY%3D 10.1016/j.molimm.2004.06.028 (Pubitemid 39361454)
29. den Dunnen, J., Gringhuis, S.I., and Geijtenbeek, T.B. (2008). Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol. Immunother. DOI 10.1007/s00262-008-0615-1.
30. L. Deng P. Dai T. Parikh H. Cao V. Bhoj Q. Sun Z. Chen T. Merghoub A. Houghton S. Shuman 2008 Vaccinia virus subverts a mitochondrial antiviral signaling proteindependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3 J. Virol. 82 10735 10746 18715932 1:CAS:528:DC%2BD1cXhtlWiur7O 10.1128/JVI.01305-08 (Pubitemid 352691180)
31. S.S. Diebold 2008 Recognition of viral single-stranded RNA by Toll-like receptors Adv. Drug Deliv. Rev. 60 813 823 18241955 1:CAS:528: DC%2BD1cXksVagsLw%3D 10.1016/j.addr.2007.11.004
32. B. Dubois C. Massacrier C. Caux 2001 Selective attraction of naive and memory B cells by dendritic cells J. Leukoc. Biol. 70 633 641 11590201 1:CAS:528:DC%2BD3MXnsFOgu7Y%3D
33. A. Fernandez-Sesma S. Marukian B.J. Ebersole D. Kaminski M.S. Park T. Yuen S.C. Sealfon A. Garcia-Sastre T.M. Moran 2006 Influenza virus evades innate and adaptive immunity via the NS1 protein J. Virol. 80 6295 6304 16775317 1:CAS:528:DC%2BD28XntFWju7o%3D 10.1128/JVI.02381-05 (Pubitemid 43927432)
34. B. Flehmig H. Staedele C. Xueref E. Vidor J. Zuckerman A. Zuckerman 1997 Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine J. Infect. 35 37 40 9279722 1:STN:280: ByiH38rmslY%3D 10.1016/S0163-4453(97)90929-4 (Pubitemid 27380034)
35. J.M. Galarza T. Latham A. Cupo 2005 Virus-like particle (VLP) vaccine conferred complete protection against a lethal influenza virus challenge Viral Immunol 18 244 251 15802970 1:CAS:528:DC%2BD2MXisl2rtro%3D 10.1089/vim.2005.18. 244 (Pubitemid 40586463)
36. D. Gatto T. Pfister A. Jegerlehner S.W. Martin M. Kopf M.F. Bachmann 2005 Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1 J. Exp. Med. 201 993 1005 15767369 1:CAS:528:DC%2BD2MXislOhu7Y%3D 10.1084/jem.20042239 (Pubitemid 40524468)
37. A.L. Gavin K. Hoebe B. Duong T. Ota C. Martin B. Beutler D. Nemazee 2006 Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling Science 314 1936 1938 17185603 1:CAS:528:DC%2BD28Xhtlemt7fN 10.1126/science.1135299 (Pubitemid 46026117)
38. R.N. Germain 2004 An innately interesting decade of research in immunology Nat. Med. 10 1307 1320 15580257 1:CAS:528:DC%2BD2cXhtVCitr7P 10.1038/nm1159 (Pubitemid 40022712)
39. A.T. Gewirtz T.A. Navas S. Lyons P.J. Godowski J.L. Madara 2001 Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression J. Immunol. 167 1882 1885 11489966 1:CAS:528:DC%2BD3MXlvFeqt7Y%3D
40. E.V. Grgacic D.A. Anderson 2006 Virus-like particles: passport to immune recognition Methods 40 60 65 16997714 1:CAS:528:DC%2BD28XpvFGhsro%3D 10.1016/j.ymeth.2006.07.018 (Pubitemid 44415499)
41. M. Gururajan J. Jacob B. Pulendran 2007 Toll-like receptor expression and responsiveness of distinct murine splenic and mucosal B-cell subsets PLoS ONE 2 e863 17848994 10.1371/journal.pone.0000863 1:CAS:528:DC%2BD2sXhtFGnu7%2FP
42. S. Gustavsson T. Kinoshita B. Heyman 1995 Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction J. Immunol. 154 6524 6528 7759885 1:CAS:528: DyaK2MXntFyis74%3D
43. R. Hai L. Martinez-Sobrido K.A. Fraser J. Ayllon A. Garcia-Sastre P. Palese 2008 Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach J. Virol. 82 10580 10590 18768976 1:CAS:528:DC%2BD1cXhtlWitbbE 10.1128/JVI.01213-08 (Pubitemid 352691164)
44. T. Hebell J.M. Ahearn D.T. Fearon 1991 Suppression of the immune response by a soluble complement receptor of B lymphocytes Science 254 102 105 1718035 1:CAS:528:DyaK3MXmtlSjsbc%3D 10.1126/science.1718035
45. H. Hemmi O. Takeuchi T. Kawai T. Kaisho S. Sato H. Sanjo M. Matsumoto K. Hoshino H. Wagner K. Takeda, et al. 2000 A Toll-like receptor recognizes bacterial DNA Nature 408 740 745 11130078 1:CAS:528:DC%2BD3cXptVCqsL0%3D 10.1038/35047123 (Pubitemid 32015992)
46. K. Hoebe E. Janssen B. Beutler 2004 The interface between innate and adaptive immunity Nat. Immunol. 5 971 974 15454919 1:CAS:528: DC%2BD2cXnvFCgsr0%3D 10.1038/ni1004-971 (Pubitemid 41057712)
47. M.C. Honorati A. Palareti P. Dolzani C.A. Busachi R. Rizzoli A. Facchini 1999 A mathematical model predicting antihepatitis B virus surface antigen (HBs) decay after vaccination against hepatitis B Clin. Exp. Immunol. 116 121 126 10209515 1:STN:280:DyaK1M3isF2qsg%3D%3D 10.1046/j.1365-2249.1999.00866.x (Pubitemid 29170014)
48. A. Jegerlehner P. Maurer J. Bessa H.J. Hinton M. Kopf M.F. Bachmann 2007 TLR9 signaling in B cells determines class switch recombination to IgG2a J. Immunol. 178 2415 2420 17277148 1:CAS:528:DC%2BD2sXht1Cns7Y%3D
49. S.M. Kaech E.J. Wherry R. Ahmed 2002 Effector and memory T-cell differentiation: implications for vaccine development Nat. Rev. Immunol. 2 251 262 12001996 1:CAS:528:DC%2BD38XjtFKhtrc%3D 10.1038/nri778
50. V. Kalia S. Sarkar T.S. Gourley B.T. Rouse R. Ahmed 2006 Differentiation of memory B and T cells Curr. Opin. Immunol. 18 255 264 16632337 1:CAS:528:DC%2BD28XktVGhsLw%3D 10.1016/j.coi.2006.03.020
51. S.M. Kang L. Guo Q. Yao I. Skountzou R.W. Compans 2004 Intranasal immunization with inactivated influenza virus enhances immune responses to coadministered simian-human immunodeficiency virus-like particle antigens J. Virol. 78 9624 9632 15331695 1:CAS:528:DC%2BD2cXnvVakurc%3D 10.1128/JVI.78.18. 9624-9632.2004 (Pubitemid 39187080)
52. T. Kawai S. Akira 2007 TLR signaling Semin. Immunol. 19 24 32 17275323 1:CAS:528:DC%2BD2sXjslGrsLY%3D 10.1016/j.smim.2006.12.004 (Pubitemid 46498752)
53. G. Kelsoe 2000 Studies of the humoral immune response Immunol. Res. 22 199 210 11339356 1:CAS:528:DC%2BD3MXjsV2rsLk%3D 10.1385/IR:22:2-3:199 (Pubitemid 32382234)
54. H. Khanlou S. Sanchez M. Babaie C. Chien G. Hamwi J.C. Ricaurte T. Stein L. Bhatti P. Denouden C. Farthing 2006 The safety and efficacy of dose-sparing intradermal administration of influenza vaccine in human immunodeficiency virus-positive patients Arch. Intern. Med. 166 1417 16832008 10.1001/archinte.166.13.1417 (Pubitemid 44036355)
55. G.G. Klaus M.B. Pepys K. Kitajima B.A. Askonas 1979 Activation of mouse complement by different classes of mouse antibody Immunology 38 687 695 521057 1:CAS:528:DyaL3cXhtVyqsLY%3D
56. M. Kopf B. Abel A. Gallimore M. Carroll M.F. Bachmann 2002 Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection Nat. Med. 8 373 378 11927943 1:CAS:528: DC%2BD38XivVGmtb4%3D 10.1038/nm0402-373 (Pubitemid 34407032)
57. S. Koyama K.J. Ishii H. Kumar T. Tanimoto C. Coban S. Uematsu T. Kawai S. Akira 2007 Differential role of TLR- and RLR-signaling in the immune responses to influenza A virus infection and vaccination J. Immunol. 179 4711 4720 17878370 1:CAS:528:DC%2BD2sXhtVCrurrJ
58. M. Kwissa S.P. Kasturi B. Pulendran 2007 The science of adjuvants Expert Rev. Vaccines 6 673 684 17931149 1:CAS:528:DC%2BD2sXhtFGgsrrN 10.1586/14760584.6.5.673 (Pubitemid 47607845)
59. R. Le Goffic V. Balloy M. Lagranderie L. Alexopoulou N. Escriou R. Flavell M. Chignard M. Si-Tahar 2006 Detrimental contribution of the Toll-like receptor (TLR)3 to influenza A virus- induced acute pneumonia PLoS Pathog 2 e53 16789835 10.1371/journal.ppat.0020053 1:CAS:528:DC%2BD28Xms1Cns7s%3D (Pubitemid 43998849)
60. H.K. Lee S. Dunzendorfer K. Soldau P.S. Tobias 2006 Double-stranded RNA-mediated TLR3 activation is enhanced by CD14 Immunity 24 153 163 16473828 1:CAS:528:DC%2BD28XitVOks70%3D 10.1016/j.immuni.2005.12.012 (Pubitemid 43214585)
61. Z. Li Y. Jiang P. Jiao A. Wang F. Zhao G. Tian X. Wang K. Yu Z. Bu H. Chen 2006 The NS1 gene contributes to the virulence of H5N1 avian influenza viruses J. Virol. 80 11115 11123 16971424 1:CAS:528:DC%2BD28Xht1KhurvN 10.1128/JVI.00993-06 (Pubitemid 44706552)
62. L. Lin A.J. Gerth S.L. Peng 2004 CpG DNA redirects class-switching towards "Th1-like" Ig isotype production via TLR9 and MyD88 Eur. J. Immunol. 34 1483 1487 15114682 1:CAS:528:DC%2BD2cXktFKitr4%3D 10.1002/eji.200324736 (Pubitemid 39256028)
63. N. Liu N. Ohnishi L. Ni S. Akira K.B. Bacon 2003 CpG directly induces T-bet expression and inhibits IgG1 and IgE switching in B cells Nat. Immunol. 4 687 693 12766768 1:CAS:528:DC%2BD3sXkvVKqu74%3D 10.1038/ni941 (Pubitemid 36874446)
64. A.D. Lobue L. Lindesmith B. Yount P.R. Harrington J.M. Thompson R.E. Johnston C.L. Moe R.S. Baric 2006 Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains Vaccine 24 5220 5234 16650512 1:CAS:528:DC%2BD28XltlemsLg%3D 10.1016/j.vaccine.2006.03.080 (Pubitemid 43818189)
65. Y.M. Loo J. Fornek N. Crochet G. Bajwa O. Perwitasari L. Martinez-Sobrido S. Akira M.A. Gill A. Garcia-Sastre M.G. Katze, et al. 2008 Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity J. Virol. 82 335 345 17942531 1:CAS:528:DC%2BD1cXhtFA%3D 10.1128/JVI.01080-07 (Pubitemid 350309149)
66. A. Mansson M. Adner U. Hockerfelt L.O. Cardell 2006 A distinct Toll-like receptor repertoire in human tonsillar B cells, directly activated by PamCSK, R-837 and CpG-2006 stimulation Immunology 118 539 548 16780564
67. R.A. Manz A.E. Hauser F. Hiepe A. Radbruch 2005 Maintenance of serum antibody levels Annu. Rev. Immunol. 23 367 386 15771575 1:CAS:528: DC%2BD2MXktFOjur0%3D 10.1146/annurev.immunol.23.021704.115723 (Pubitemid 40563174)
68. D. Markine-Goriaynoff J.T. van der Logt C. Truyens T.D. Nguyen F.W. Heessen G. Bigaignon Y. Carlier J.P. Coutelier 2000 IFN-gamma-independent IgG2a production in mice infected with viruses and parasites Int. Immunol. 12 223 230 10653858 1:CAS:528:DC%2BD3cXhsVyhsbc%3D 10.1093/intimm/12.2.223
69. M. Martin S.M. Michalek J. Katz 2003 Role of innate immune factors in the adjuvant activity of monophosphoryl lipid A Infect. Immun. 71 2498 2507 12704121 1:CAS:528:DC%2BD3sXjtl2itLY%3D 10.1128/IAI.71.5.2498-2507.2003 (Pubitemid 36519862)
70. L.J. McHeyzer-Williams M.G. McHeyzer-Williams 2005 Antigen-specific memory B cell development Annu. Rev. Immunol. 23 487 513 15771579 1:CAS:528:DC%2BD2MXktFOjurk%3D 10.1146/annurev.immunol.23.021704.115732 (Pubitemid 40563178)
71. A. Meyer-Bahlburg S. Khim D.J. Rawlings 2007 B cell intrinsic TLR signals amplify but are not required for humoral immunity J. Exp. Med. 204 3095 3101 18039950 1:CAS:528:DC%2BD1cXktVenug%3D%3D 10.1084/jem.20071250
72. H.A. Minges Wols G.H. Underhill G.S. Kansas P.L. Witte 2002 The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity J. Immunol. 169 4213 4221 12370351
73. E. Mortola P. Roy 2004 Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system FEBS Lett. 576 174 178 15474033 1:CAS:528:DC%2BD2cXot12htr0%3D 10.1016/j.febslet.2004.09.009 (Pubitemid 39330479)
74. D. Nemazee A. Gavin K. Hoebe B. Beutler 2006 Immunology: Toll-like receptors and antibody responses Nature 441 E4 16710369 1:CAS:528: DC%2BD28Xksleltbs%3D 10.1038/nature04875 (Pubitemid 44050162)
75. F. Nimmerjahn J.V. Ravetch 2005 Divergent immunoglobulin g subclass activity through selective Fc receptor binding Science 310 1510 1512 16322460 1:CAS:528:DC%2BD2MXht1GqsrjM 10.1126/science.1118948 (Pubitemid 41746349)
76. A.F. Ochsenbein D.D. Pinschewer B. Odermatt M.C. Carroll H. Hengartner R.M. Zinkernagel 1999 Protective T cellindependent antiviral antibody responses are dependent on complement J. Exp. Med. 190 1165 1174 10523614 1:CAS:528:DyaK1MXmslKis7g%3D 10.1084/jem.190.8.1165 (Pubitemid 29496509)
77. P. Palese T. Muster H. Zheng R. O'Neill A. Garcia-Sastre 1999 Learning from our foes: a novel vaccine concept for influenza virus Arch. Virol. Suppl. 15 131 138 10470274 1:STN:280:DyaK1MzpvFalsg%3D%3D
78. A.K. Palucka B. Laupeze C. Aspord H. Saito G. Jego J. Fay S. Paczesny V. Pascual J. Banchereau 2005 Immunotherapy via dendritic cells Adv. Exp. Med. Biol. 560 105 114 15932026 1:CAS:528:DC%2BD2MXhtlCjsLrM 10.1007/0-387-24180-9-14
79. C. Pasare R. Medzhitov 2004 Toll-like receptors: linking innate and adaptive immunity Microbes Infect. 6 1382 1387 15596124 1:CAS:528: DC%2BD2cXhtVOntbbP 10.1016/j.micinf.2004.08.018 (Pubitemid 41110581)
80. C. Pasare R. Medzhitov 2005 Control of B-cell responses by Toll-like receptors Nature 438 364 368 16292312 1:CAS:528:DC%2BD2MXht1WksbfP 10.1038/nature04267 (Pubitemid 41643953)
81. A. Pashine N.M. Valiante J.B. Ulmer 2005 Targeting the innate immune response with improved vaccine adjuvants Nat. Med. 11 S63 68 15812492 1:CAS:528:DC%2BD2MXjsFWmsrg%3D 10.1038/nm1210 (Pubitemid 40562305)
82. D.H. Persing R.N. Coler M.J. Lacy D.A. Johnson J.R. Baldridge R.M. Hershberg S.G. Reed 2002 Taking toll: lipid A mimetics as adjuvants and immunomodulators Trends Microbiol 10 S32 7 12377566 1:CAS:528: DC%2BD38XnsF2ktbs%3D 10.1016/S0966-842X(02)02426-5
83. M.E. Pichichero T. Voloshen S. Passador 1999 Kinetics of booster responses to Haemophilus influenzae type B conjugate after combined diphtheria-tetanus-acelluar pertussis-Haemophilus influenzae type b vaccination in infants Pediatr. Infect. Dis. J. 18 1106 1108 10608637 1:STN:280: DC%2BD3c%2FnsVenuw%3D%3D 10.1097/00006454-199912000-00019
84. S.A. Plotkin 2005 Vaccines: past, present and future Nat. Med. 11 S5 11 15812490 1:CAS:528:DC%2BD2MXjsFWnu7Y%3D 10.1038/nm1209 (Pubitemid 40562297)
85. B. Pulendran 2004 Modulating vaccine responses with dendritic cells and Toll-like receptors Immunol. Rev. 199 227 250 15233738 1:CAS:528: DC%2BD2cXltFygsb4%3D 10.1111/j.0105-2896.2004.00144.x (Pubitemid 38736775)
86. B. Pulendran R. Ahmed 2006 Translating innate immunity into immunological memory: implications for vaccine development Cell 124 849 863 16497593 1:CAS:528:DC%2BD28Xit1Kltbg%3D 10.1016/j.cell.2006.02.019 (Pubitemid 43261457)
87. P. Pushko T.M. Tumpey F. Bu J. Knell R. Robinson G. Smith 2005 Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice Vaccine 23 5751 5759 16143432 1:CAS:528:DC%2BD2MXht1GhtbzN 10.1016/j.vaccine.2005.07.098 (Pubitemid 41668881)
88. F.S. Quan C. Huang R.W. Compans S.M. Kang 2007 Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus J. Virol. 81 3514 3524 17251294 1:CAS:528: DC%2BD2sXjslWqsLw%3D 10.1128/JVI.02052-06 (Pubitemid 46456660)
89. F.S. Quan G. Sailaja I. Skountzou C. Huang A. Vzorov R.W. Compans S.M. Kang 2007 Immunogenicity of viruslike particles containing modified human immunodeficiency virus envelope proteins Vaccine 25 3841 3850 17320250 1:CAS:528:DC%2BD2sXksV2qs7o%3D 10.1016/j.vaccine.2007.01.107 (Pubitemid 46589751)
90. F.S. Quan R.W. Compans H.H. Nguyen S.M. Kang 2008 Induction of heterosubtypic immunity to influenza virus by intranasal immunization J. Virol. 82 1350 1359 18032492 1:CAS:528:DC%2BD1cXhtFOktb0%3D 10.1128/JVI.01615-07
91. F.S. Quan D. Steinhauer C. Huang T.M. Ross R.W. Compans S.M. Kang 2008 A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs Vaccine 26 3352 3361 18468740 1:CAS:528:DC%2BD1cXnt1Smurg%3D 10.1016/j.vaccine.2008.03.055
92. T. Querec S. Bennouna S. Alkan Y. Laouar K. Gorden R. Flavell S. Akira R. Ahmed B. Pulendran 2006 Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity J. Exp. Med. 203 413 424 16461338 10.1084/jem.20051720 (Pubitemid 43290850)
93. R. Rappuoli 2004 From Pasteur to genomics: progress and challenges in infectious diseases Nat. Med. 10 1177 1185 15516917 1:CAS:528: DC%2BD2cXptVOgtrg%3D 10.1038/nm1129 (Pubitemid 39540432)
94. R. Rappuoli 2007 Bridging the knowledge gaps in vaccine design Nat. Biotechnol. 25 1361 1366 18066025 1:CAS:528:DC%2BD2sXhsVSjurfJ 10.1038/nbt1207-1361 (Pubitemid 350233122)
95. K. Reif E.H. Ekland L. Ohl H. Nakano M. Lipp R. Forster J.G. Cyster 2002 Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position Nature 416 94 99 11882900 10.1038/416094a (Pubitemid 34215407)
96. A. Ridderstad D.M. Tarlinton 1998 Kinetics of establishing the memory B cell population as revealed by CD38 expression J. Immunol. 160 4688 4695 9590214 1:CAS:528:DyaK1cXjtVansLk%3D
97. G. Sailaja I. Skountzou F.S. Quan R.W. Compans S.M. Kang 2007 Human immunodeficiency virus-like particles activate multiple types of immune cells Virology 362 331 341 17276476 1:CAS:528:DC%2BD2sXkvFOjt7g%3D 10.1016/j.virol.2006.12.014 (Pubitemid 46678140)
98. D. Sancho M. Gomez F. Sanchez-Madrid 2005 CD69 is an immunoregulatory molecule induced following activation Trends Immunol. 26 136 140 15745855 1:CAS:528:DC%2BD2MXhvF2gt7c%3D 10.1016/j.it.2004.12.006 (Pubitemid 40312520)
99. M. Schnare G.M. Barton A.C. Holt K. Takeda S. Akira R. Medzhitov 2001 Toll-like receptors control activation of adaptive immune responses Nat. Immunol. 2 947 950 11547333 1:CAS:528:DC%2BD3MXnsVCis74%3D 10.1038/ni712 (Pubitemid 32976167)
100. M. Shapiro-Shelef K. Calame 2005 Regulation of plasmacell development Nat. Rev. Immunol. 5 230 242 15738953 1:CAS:528:DC%2BD2MXhslSju7s%3D 10.1038/nri1572 (Pubitemid 40364824)
101. D. Shin C.S. Yang J.Y. Lee S.J. Lee H.H. Choi H.M. Lee J.M. Yuk C.V. Harding E.K. Jo 2008 Mycobacterium tuberculosis lipoprotein-induced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages Cell Microbiol 10 1893 1905 18503635 1:CAS:528:DC%2BD1cXhtVCrsLfI 10.1111/j.1462-5822.2008.01179.x
102. S.M. Shinall M. Gonzalez-Fernandez R.J. Noelle T.J. Waldschmidt 2000 Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens J. Immunol. 164 5729 5738 10820250 1:CAS:528:DC%2BD3cXjslemtrs%3D
103. Y. Sun R. Carrion Jr. L. Ye Z. Wen Y.T. Ro K. Brasky A.E. Ticer E.E. Schwegler J.L. Patterson R.W. Compans, et al. 2009 Protection against lethal challenge by Ebola virus-like particles produced in insect cells Virology 538 12 21 10.1016/j.virol.2008.09.020 1:CAS:528:DC%2BD1cXhsVKqsb%2FP
104. K. Takeda S. Akira 2004 TLR signaling pathways Semin. Immunol. 16 3 9 14751757 1:CAS:528:DC%2BD2cXntVOnsA%3D%3D 10.1016/j.smim.2003.10.003 (Pubitemid 38147427)
105. F. Takeshita K. Kobiyama A. Miyawaki N. Jounai K. Okuda 2008 The non-canonical role of Atg family members as suppressors of innate antiviral immune signaling Autophagy 4 67 69 17921696 1:CAS:528:DC%2BD1cXks1Sgsr4%3D
106. J. Talon M. Salvatore R. E. O'Neill Y. Nakaya H. Zheng T. Muster A. Garcia-Sastre P. Palese 2000 Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach Proc. Natl. Acad. Sci. USA 97 4309 4314 10725408 1:CAS:528:DC%2BD3cXislSnsrY%3D 10.1073/pnas.070525997 (Pubitemid 30226129)
107. L. Tiberio L. Fletcher J.H. Eldridge D.D. Duncan 2004 Host factors impacting the innate response in humans to the candidate adjuvants RC529 and monophosphoryl lipid A Vaccine 22 1515 1523 15063577 1:CAS:528: DC%2BD2cXivVCqu78%3D 10.1016/j.vaccine.2003.10.019 (Pubitemid 38446930)
108. L. Unterholzner A.G. Bowie 2008 The interplay between viruses and innate immune signaling: recent insights and therapeutic opportunities Biochem. Pharmacol. 75 589 602 17868652 1:CAS:528:DC%2BD1cXlvVOhsA%3D%3D 10.1016/j.bcp.2007.07.043
109. P. Van Damme F. Oosterhuis-Kafeja M. Van der Wielen Y. Almagor O. Sharon Y. Levin 2009 Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults Vaccine 27 454 459 19022318 10.1016/j.vaccine.2008.10.077
110. K.F. van der Sluijs L. van Elden M. Nijhuis R. Schuurman S. Florquin H.M. Jansen R. Lutter T. van der Poll 2003 Toll-like receptor 4 is not involved in host defense against respiratory tract infection with Sendai virus Immunol. Lett. 89 201 206 14556979 10.1016/S0165-2478(03)00138-X 1:CAS:528: DC%2BD3sXnvFWitLo%3D (Pubitemid 37222447)
111. D. van Duin R. Medzhitov A.C. Shaw 2006 Triggering TLR signaling in vaccination Trends Immunol 27 49 55 16310411 10.1016/j.it.2005.11.005 1:CAS:528:DC%2BD28XmsVyluw%3D%3D (Pubitemid 43083564)
112. K. Van Herck P. Beutels P. Van Damme M. Beutels J. Van den Dries P. Briantais E. Vidor 2000 Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines J. Med. Virol. 60 1 7 10568755 10.1002/(SICI)1096-9071(200001)60: 1<1::AID-JMV1>3.0.CO;2-H
113. C.G. Vinuesa S.G. Tangye B. Moser C.R. Mackay 2005 Follicular B helper T cells in antibody responses and autoimmunity Nat. Rev. Immunol. 5 853 865 16261173 1:CAS:528:DC%2BD2MXhtFKls7jK 10.1038/nri1714 (Pubitemid 41581667)
114. K.L. Warfield D.L. Swenson G. Demmin S. Bavari 2005 Filovirus-like particles as vaccines and discovery tools Expert Rev. Vaccines 4 429 440 16026254 1:CAS:528:DC%2BD2MXntVGrtL4%3D 10.1586/14760584.4.3.429 (Pubitemid 40978702)